HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 196 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $310,000 | -92.6% | 18,355 | -91.5% | 0.08% | -85.5% |
| Q1 2018 | $4,210,000 | +266.1% | 214,887 | +278.5% | 0.59% | +324.6% |
| Q4 2017 | $1,150,000 | +55.6% | 56,773 | +33.4% | 0.14% | +70.4% |
| Q3 2017 | $739,000 | +84.3% | 42,573 | +36.1% | 0.08% | +65.3% |
| Q2 2017 | $401,000 | +2.8% | 31,273 | +4.0% | 0.05% | +2.1% |
| Q1 2017 | $390,000 | +124.1% | 30,073 | +71.1% | 0.05% | +54.8% |
| Q4 2016 | $174,000 | -17.9% | 17,573 | 0.0% | 0.03% | -38.0% |
| Q3 2016 | $212,000 | +29.3% | 17,573 | -7.4% | 0.05% | +22.0% |
| Q2 2016 | $164,000 | -65.0% | 18,973 | -61.7% | 0.04% | -73.0% |
| Q1 2016 | $469,000 | -23.5% | 49,573 | +40.0% | 0.15% | -58.8% |
| Q4 2015 | $613,000 | – | 35,400 | – | 0.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 7,048,282 | $126,799,000 | 27.23% |
| First Light Asset Management, LLC | 1,630,591 | $29,334,000 | 5.01% |
| SNYDER CAPITAL MANAGEMENT L P | 3,393,057 | $61,041,000 | 3.48% |
| Bellevue Group AG | 7,663,956 | $137,874,000 | 2.67% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 307,633 | $5,531,000 | 2.52% |
| Lombard Odier Asset Management (Switzerland) SA | 900,000 | $16,191,000 | 2.17% |
| Elk Creek Partners, LLC | 654,362 | $11,772,000 | 2.02% |
| DOHENY ASSET MANAGEMENT /CA | 127,110 | $2,254,000 | 1.79% |
| Granite Investment Partners, LLC | 1,277,438 | $22,981,000 | 1.49% |
| Amia Capital LLP | 69,409 | $1,249,000 | 1.11% |